Micropulse Laser

DEVICE6 trials

Conditions

Acute Central Serous Retinopathy With Subretinal FluidCenter-Involved Diabetic Macular EdemaCentral Serous ChorioretinopathyDiabetic Macular EdemaInitialMicropulse LaserRefractoryTreatment

Phase 2

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

CompletedNCT03143192

Keyvan KoushanDiabetic Macular Edema

Start: 2017-03-08End: 2019-05-09Updated: 2019-09-10

Phase 4

Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

CompletedNCT03690947

Beijing HospitalDiabetic Macular Edema

Start: 2018-10-01End: 2021-09-30Updated: 2022-12-28

Unknown Phase

Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema

CompletedNCT04014556

University of AlexandriaDiabetic Macular Edema

Start: 2016-04-01End: 2018-12-01Updated: 2019-07-10

Subthreshold Micropulse Laser Treatment of Acute Central Serous Chorioretinopathy

CompletedNCT05447117

Minia UniversityAcute Central Serous Retinopathy With Subretinal Fluid

Start: 2019-10-15End: 2022-06-30Updated: 2022-09-13

Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE

WithdrawnNCT05679180

University Hospital, BordeauxCentral Serous Chorioretinopathy

Start: 2023-05-11End: 2023-05-24Updated: 2023-05-30

Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema

RecruitingNCT07295704

The General Authority for Teaching Hospitals and InstitutesCenter-Involved Diabetic Macular Edema, Initial, Micropulse Laser +2

Start: 2025-10-15End: 2026-03-30Target: 50Updated: 2025-12-22

Related Papers

The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.

2022-09-023 citations

Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)